Selective enhancement of 5-hydroxytryptamine-induced contraction of porcine coronary artery by oxidized low-density lipoprotein

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 3, 1996, Pages 1095-1103

  Cox, David A ^a   Cohen, Marlene L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BRADYKININ; LIPOPROTEIN; NITROPRUSSIDE SODIUM; SEROTONIN;

ANIMAL; ARTICLE; CORONARY BLOOD VESSEL; DOSE RESPONSE; DRUG EFFECT; SWINE; VASOCONSTRICTION;

ACETYLCHOLINE; ANIMALS; BRADYKININ; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPROTEINS; NITROPRUSSIDE; SEROTONIN; SWINE; VASOCONSTRICTION;

EID: 0030111350     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. ANDERSON, T. J., MEREDITH, I. T., YEUNG, A. C., FREI, B., SELWYN, A. P. AND GANZ, P.: The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N. Engl. J. Med. 332: 488-493, 1995.
2. BERGMANN, S. R., FERGUSON, B. T., JR. AND SOBEL, B. E.: Effects of amphiphiles on erythrocytes, coronary arteries, and perfused hearts. Am. J. Physiol. 240: H229-H237, 1981.
3. BOULANGER, C. M., TANNER, F. C , BEA, M. L., HAHN, A. W. A., WERNER, A. AND LUSCHER, T F.: Oxidized low density lipoprotein induce mRNA expression and release of endothelin from human and porcine endothelium. Circ. Res. 70: 1191-1197, 1992.
4. CAZZOLATO, G., AVOGARO, P. AND BITTOLO-BON, G.: Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Radic. Biol. Med. 11: 247-253, 1991
5. CHIN, J. H., SALMAN, A. AND HOFFMAN, B. B.: Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J. Clin. Invest. 89: 10-18, 1992.
6. COHEN, R. A., SHEPHERD, J. T. AND VANHOUTTE, P. M.: 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries. Am. J. Physiol. 245: H1077-H1080, 1983.
7. COHEN, R A., ZITNAY, K. M., HAUDENSCHILD, C. C AND CUNNINGHAM, L. D.: Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ. Res. 63: 903-910, 1988.
8. COX, D. A., SUSEMICHEL, A. D. AND COHEN, M. L.: Selective endothelial dysfunction in porcine coronary artery produced by incubation in cell culture medium in vitro. Endothelium 3: 171-179, 1995.
9. COX, D. A. AND COHEN, M. L.: Effects of oxidized LDL on vascular contraction and relaxation: Clinical and pharmacological implications in atherosclerosis. Pharmacol. Rev., in press, 1996.
10. COX, D. A., VITA, J. A., TREASURE, C. B., FISH, R. B., ALEXANDER, R. W., CANZ, P. AND SELWYN, A. P.: Atherosclerosis impairs flow-mediated dilation of coronary arteries in man. Circulation 80: 458-465, 1989.
11. CREAGER, M. A., COOKE, J. P., MENDELSOHN, M. E., GALLAGHER, S. J , COLEMAN, S. M., LOSCALZO, J AND DZAU, V. J.: Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86: 228-234, 1990.
12. CUSHING, D. J.,AND COHEN, M. L.: Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery. J. Pharmacol. Exp. Ther. 261: 856-862, 1992.
13. DAUGHERTY, A., ZWEIFEL, B S., SOBEL, B. E. AND SCHONFELD, G.: Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits Arteriosclerosis 8: 768-777, 1988.
14. DELEAN, A., MUNSON, P. J. AND RODBARD, D.: Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assays, and physiological dose-response curves. Am. J. Physiol. 235: E97-E102, 1978.
15. GALLE, J., BASSENGE, E. AND BUSSE, R.: Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ. Res. 66: 1287-1293, 1990.
16. GALLE, J. AND BASSENGE, E.: Effects of native and oxidized low-density lipoproteins on endothelium-dependent and endothelium-independent vasomotion. Basic Res. Cardiol. 86: (Suppl 2), 127-142, 1991.
17. GALLE, J., MULSCH, A , BUSSE, R. AND BASSENGE, E.: Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler. Thromb. 11: 198-203, 1991.
18. GILLIGAN, D. M., GUETTA, V , PANZA, J. A., GARCIA, C. E., QUYYUMI, A. A. AND CANNON, R. O.: Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 90: 35-41, 1994.
19. GOLINO, P., PISCIONE, F., WILLERSON, J. T., CAPPELLI-BIGAZZI, M., FOCACCIO, A., VILLARI, B., INDOLFI, C., RUSSOLILLO, E., CONDORELLI, M. AND CHIARIELLO, M.: Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N. Engl. J. Med. 324: 641-648, 1991.
20. HAYASHI, T., ISHIKAWA, T., KUZUYA, M., NAITO, M., YAMADA, K., ASAI, K , HIDAKA, H. AND IGUCHI, A.: Chelation of copper reduces inhibition by oxidized lipoproteins of endothelium-dependent relaxation in porcine coronary arteries. Heart Vessels 9: 283-291, 1994.
21. HODIS, H. N., KRAMSCH, K. M., AVOGARA, P., BITTOLO-BON, G., CAZZOLATO, G., HWANG, J., PETERSON, H., AND SEVANIAN, A.: Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). J. Lipid Res. 35: 669-677, 1994.
22. HOLZMANN, S., KUKOVETZ, W. R., WINDISCHHOFER, W., PASCHKE, E., GRAIER, W. F : Pharmacological differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries. J Cardiovasc. Pharmacol. 23: 747-756, 1994.
23. KALSNER, S : Coronary artery spasm. Multiple causes and multiple roles in heart disease. Biochem. Pharmacol. 49: 859-871, 1995.
24. KANNEL, W. B., CASTELLI, W. P , GORDON, T. AND MCNAMARA, P. M.: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. Ann. Intern. Med. 74: 1-12, 1971
25. KEANEY, J. F., JR., GAZIANO, J. M., XU, A., FREI, B., CURRAN-CELENTANO, J., SHWAERY, G. T., LOSCALZO, J. AND VITA, J A.: Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J. Clin. Invest. 93: 844-851, 1994.
26. KUGIYAMA, K., KERNS, S. A., MORRISETT, J. D., ROBERTS, R , HENRY, P. D.: Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 344: 160-162, 1990.
27. LAMPING, K. G., PIEGORS, D. J., BENZULY, K. H., ARMSTRONG, M. L. AND HEISTAD, D. D.: Enhanced coronary vasoconstrictive response to serotonin subsides after removal of dietary cholesterol in atherosclerotic monkeys. Arterioscler. Thromb. 14: 951-957, 1994.
28. LIAO, J. K., SHIN, W. S., LEE, W. Y. AND CLARK, S. L.: Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J. Biol. Chem. 270: 319-324, 1995.
29. LUDMER, P. L., SELWYN, A. P., SHOOK, T L., WAYNE, R. R., MUDGE, G. H., ALEXANDER, R. W. AND GANZ, P.: Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J Med. 315: 1046-1051, 1986.
30. MCFADDEN, E. P., CLARKE, J. G., DAVIES, G. J , KASKI, J. C., HAIDER, A. W. AND MASERI, A.: Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N. Engl. J. Med. 324: 648-654, 1991.
31. 2+ mobilization causes supersensitivity of contractile response to serotonin in atherosclerotic arteries. Circ. Res. 75: 1096-1102, 1994.
32. MUROHARA, T., KUGIYAMA, K., OHGUSHI, M., SUGIYAMA, S., OHTA, Y. AND YASUE, H.: LPC in oxidized LDL elicits vasoconstriction and inhibits endothelium-dependent relaxation. Am. J. Physiol. 267: H2441-H2449, 1994.
33. MYERS, P. R., WRIGHT, T. F., TANNER, M. A. AND OSTLUND, R. E.: The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium. J. Lab. Clin. Med. 124: 672-683, 1994.
34. NABEL, E. G., GANZ, P., GORDON, J. B., ALEXANDER, R. W. AND SELWYN, A. P.: Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 77: 43-52, 1988.
35. NIU, X. L., LIU, L -Y., HU, M.-L. AND CHEN, X.: Some similarities in vascular effects of oleic acid and oxidized low-density lipoproteins on rabbit aorta. J. Mol. Cell. Cardiol. 27: 531-539, 1995
36. OHGUSHI, M., KUGIYAMA, K., FUKUNAGA, K., MUROHARA, T., SUGIYAMA, S., MIYAMOTO, E. AND YASUE, H.: Protein kinase C inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL. Arterioscler. Thromb. 13: 1525-1532, 1993.
37. PALINSKI, W., ROSENFELD, M. E., YLA-HERTTUALA, S., GURTNER, G. C., SOCHER, S S., BUTLER, S. W., PASTHASAKATHY, S., CAREW, T. E., STEINBERG, D AND WITZTUM, J. L.: Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad Sci USA 86: 1372-1376, 1989.
38. PLANE, F., BRUCKDORFER, K. R., KERR, P., STEUER, A. AND JACOBS, M.: Oxidative modification of low-density lipoprotein and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Eur. J. Pharmacol. 105: 216-222, 1992.
39. 1D receptor subtype. J. Pharmacol. Exp. Ther. 252: 387-395, 1990.
40. SHIMOKAWA, H. AND VANHOUTTE, P. M.: Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ. Res. 64: 900-914, 1989.
41. SIMON, B. C., CUNNINGHAM, L. D. AND COHEN, R. A.: Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J. Clin. Invest. 86: 75-79, 1990.
42. STEPP, D. W. AND TULENKO, T. N.: Alterations in basal and serotonin-stimulated calcium permeability and vasoconstriction in atherosclerotic aorta. Arterioscler. Thromb. 14: 1854-1859, 1994.
43. STEWART-LEE, A. L , FORSTER, L. A , NOUROOZ-ZADEH, J., FERNS, G. A. A. AND ANGGARD, E. E.: Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arterioscler. Thromb. 14: 494-499, 1994.
44. SUGIYAMA, S., KUGIYAMA, K., OHGUSHI, M., FUJIMOTO, K. AND YASUE, H.: Lysophosphatidylcholine in oxidized low-density lipoprotein increases endothelial susceptibility to polymorphonuclear leukocyte-induced endothelial dysfunction in porcine coronary arteries. Role of protein kinase C. Circ. Res. 74: 565-575, 1994.
45. TANNER, F. C., NOLL, G , BOULANGER, C. M. AND LUSCHER, T. F. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide. Circulation 83: 2012-2020, 1991.
46. VIDAVER, G. A., TING, A. AND LEE, J. W.: Evidence that lysolecithin is an important causal agent of atherosclerosis. J. Ther. Biol. 115: 27-41, 1985.
47. VERBEUREN, T. J.: Endothelium and coronary atherosclerosis. Coronary Art. Dis. 2: 323-337, 1991.
48. YAGI, K.: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem. Med. 15: 212-216, 1976.
49. YLA-HERTTUALA, S., PALINSKI, W., ROSENFELD, M. E., PARTHASARATHY, S., CAREW, T. E., BUTLER, S., WITZTUM, J. L. AND STEINBERG, D.: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095, 1989.
50. YOKOHAMA, M., HIRATA, K., MIYAKE, R., AKITA, H., ISHIKAWA, Y. AND FUKUZAKI, H.: Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem. Biophys. Res. Commun. 168: 301-308, 1990.
51. YOUNG, S. G. AND PARTHASARATHY, S.: Why are low-density lipoproteinS atherogenic? West. J. Med. 160: 153-164, 1994.
52. ZEIHER, A. M. AND SCHACHINGER, V.: Coronary endothelial vasodilator dysfunction: Clinical relevance and therapeutic implications. Z. Kardiol. 83: (Suppl. 3), 7-14, 1994.